NCT01254617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +66 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Recurrent Oral Cavity Verrucous Carcinoma
Explore clinical trials studying Recurrent Oral Cavity Verrucous Carcinoma. Study availability and eligibility vary by location and protocol.
5 public trials
0 recruiting studies
Recurrent Oral Cavity Verrucous Carcinoma trial results
NCT01256385
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Northwestern University Chicago, Illinois, United States
NCT02007200
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +42 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT00458978
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +36 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Active, Not Recruiting
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT00588770
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States